Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 178,584,304
  • Shares Outstanding, K 956,582
  • Annual Sales, $ 22,320 M
  • Annual Income, $ 8,318 M
  • 60-Month Beta 0.37
  • Price/Sales 7.34
  • Price/Cash Flow 26.19
  • Price/Book 34.24
Trade LLY with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 2.34
  • Number of Estimates 5
  • High Estimate 2.44
  • Low Estimate 2.23
  • Prior Year 1.73
  • Growth Rate Est. (year over year) +35.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
161.78 +17.92%
on 01/07/21
191.78 -0.53%
on 01/15/21
+23.34 (+13.94%)
since 12/15/20
3-Month
129.21 +47.64%
on 10/30/20
191.78 -0.53%
on 01/15/21
+43.99 (+29.97%)
since 10/15/20
52-Week
117.06 +62.97%
on 03/23/20
191.78 -0.53%
on 01/15/21
+49.66 (+35.19%)
since 01/15/20

Most Recent Stories

More News
Lilly Confirms Date and Conference Call for Fourth-Quarter 2020 Financial Results Announcement

, /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter and full-year 2020 financial results on . Lilly will also conduct a conference call on that day with the investment...

LLY : 190.77 (+2.19%)
Pharma Stock Roundup: LLY's Alzheimer Disease Data, NVS & SNY's M&A Deals

Lilly's (LLY) candidate, donanemab shows slowing of cognitive decline in Alzheimer's disease patients. Novartis (NVS) and Sanofi (SNY) announce M&A deals.

SNY : 49.39 (+0.73%)
RHHBY : 44.5600 (+1.39%)
PFE : 36.70 (-0.14%)
MRK : 83.38 (+1.47%)
LLY : 190.77 (+2.19%)
GSK : 38.47 (+0.81%)
NVS : 95.63 (+1.07%)
Lilly Announces $30 Million Limited Partner Investment in Unseen Capital Health Fund

, /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced a limited partner investment in Unseen Capital Health Fund LP, a newly-formed venture fund created by racially diverse and historically...

LLY : 190.77 (+2.19%)
The Zacks Analyst Blog Highlights: Amazon, Thermo Fisher, Eli Lilly, Google and CVS Health

The Zacks Analyst Blog Highlights: Amazon, Thermo Fisher, Eli Lilly, Google and CVS Health

AMZN : 3,104.25 (-0.74%)
CVS : 76.26 (+1.61%)
LLY : 190.77 (+2.19%)
TMO : 503.14 (+1.25%)
GOOGL : 1,727.62 (-0.19%)
Gabrielle Sulzberger Elected to Lilly Board of Directors

, /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has elected as a new member, effective . As a member of Lilly's board, she will serve on both the Audit Committee and the...

LLY : 190.77 (+2.19%)
Top Analyst Reports for Amazon, Thermo Fisher & Eli Lilly

Top Analyst Reports for Amazon, Thermo Fisher & Eli Lilly

TMO : 503.14 (+1.25%)
NVO : 72.03 (+1.41%)
LLY : 190.77 (+2.19%)
GOOGL : 1,727.62 (-0.19%)
CVS : 76.26 (+1.61%)
AMZN : 3,104.25 (-0.74%)
Diamondback Energy, Ryman Hospitality Properties, Eli Lilly, Biogen and Roche highlighted as Zacks Bull and Bear of the Day

Diamondback Energy, Ryman Hospitality Properties, Eli Lilly, Biogen and Roche highlighted as Zacks Bull and Bear of the Day

BIIB : 275.84 (-1.59%)
RHHBY : 44.5600 (+1.39%)
LLY : 190.77 (+2.19%)
RHP : 67.76 (-2.21%)
FANG : 59.24 (-4.35%)
The Latest: Fla. lawyer in tobacco cases dies from COVID-19

PENSACOLA, Fla. — Florida attorney Fred Levin, who won a major legal battle against the tobacco industry in the 1990s, has died several days after contracting the coronavirus. He was 83.

LLY : 190.77 (+2.19%)
PFE : 36.70 (-0.14%)
A Guide to Biotech ETF Investing Amid the Coronavirus Crisis

The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.

PFE : 36.70 (-0.14%)
MRNA : 129.65 (-0.05%)
LLY : 190.77 (+2.19%)
IBB : 161.71 (-0.10%)
CNCR : 34.65 (-1.00%)
XBI : 151.73 (-1.11%)
BBH : 180.97 (+0.53%)
FBT : 176.29 (+0.05%)
SBIO : 56.23 (-1.00%)
PBE : 76.14 (-0.12%)
BTEC : 63.68 (-0.75%)
ARKG : 107.96 (-1.23%)
BNTX : 101.59 (-4.02%)
Lilly's (LLY) Alzheimer's Drug Promising in Mid-Stage Study

Lilly (LLY) announces data from a phase II study on its Alzheimer's disease candidate, donanemab, which shows slowing of cognitive decline.

BIIB : 275.84 (-1.59%)
RHHBY : 44.5600 (+1.39%)
PFE : 36.70 (-0.14%)
LLY : 190.77 (+2.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their...

See More

Key Turning Points

3rd Resistance Point 197.75
2nd Resistance Point 194.76
1st Resistance Point 192.77
Last Price 190.77
1st Support Level 187.79
2nd Support Level 184.80
3rd Support Level 182.81

See More

52-Week High 191.78
Last Price 190.77
Fibonacci 61.8% 163.24
Fibonacci 50% 154.42
Fibonacci 38.2% 145.60
52-Week Low 117.06

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar